“RBC Sees 40%-Plus Upside in These 3 Stocks”
March 19, 2021
“Splunk, Inc. (SPLK)…
The majority of the Street concurs, as among the 17 analysts to have published a call on SPLK over the last 3 months, 10 say Buy and 7 suggest Hold. SPLK’s Moderate Buy consensus rating is accompanied with a $199.19 price target, suggesting 47% upside…
GoodRx Holdings (GDRX)…
RBC is on the bullish end of the Wall Street reviews – this stock has received coverage from 9 analysts, and they are split 5 to 4 in favor of Buy versus Hold. This gives the stock a Moderate Buy consensus rating. The current share price is $38.05, and the stock’s average price target, at $50.63, suggests it has a 33% upside ahead of it…
Gamida Cell (GMDA)…
Wall Street was clearly impressed by Gamida’s results, as the stock has a unanimous Strong Buy consensus rating, based on 6 recent Buy-side reviews. The stock is selling for $8.95, and its $19 average price target suggests a one-year upside of 112%…”
https://finance.yahoo.com/news/rbc-sees-40-plus-upside-163631526.html